Colgate-Palmolive (NYSE:CL) Shares Acquired by Capital Advisory Group Advisory Services LLC

Capital Advisory Group Advisory Services LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,830 shares of the company’s stock after purchasing an additional 132 shares during the quarter. Capital Advisory Group Advisory Services LLC’s holdings in Colgate-Palmolive were worth $348,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Cordatus Wealth Management LLC lifted its stake in Colgate-Palmolive by 1.1% during the 4th quarter. Cordatus Wealth Management LLC now owns 22,915 shares of the company’s stock valued at $2,083,000 after acquiring an additional 251 shares during the period. Centricity Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter worth $27,000. Nicholson Wealth Management Group LLC lifted its position in Colgate-Palmolive by 141.2% during the fourth quarter. Nicholson Wealth Management Group LLC now owns 15,906 shares of the company’s stock valued at $1,446,000 after purchasing an additional 9,311 shares during the period. Mattern Capital Management LLC boosted its holdings in Colgate-Palmolive by 2.9% in the fourth quarter. Mattern Capital Management LLC now owns 94,805 shares of the company’s stock valued at $8,619,000 after purchasing an additional 2,642 shares during the last quarter. Finally, Forte Capital LLC ADV grew its position in Colgate-Palmolive by 3.4% during the 4th quarter. Forte Capital LLC ADV now owns 19,133 shares of the company’s stock worth $1,739,000 after purchasing an additional 627 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $87.80 on Friday. The firm has a 50-day simple moving average of $89.02 and a 200-day simple moving average of $95.99. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $71.25 billion, a price-to-earnings ratio of 24.94, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $84.45 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business posted $0.87 earnings per share. On average, equities analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.28%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CL. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. UBS Group decreased their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Finally, StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.